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A dysfunctional bone marrow (BM) microenviron-
ment is thought to contribute to the development of
hematologic diseases. However, functional replace-
ment of pathologic BM microenvironment through
BM transplantation has not been possible. Further-
more, the study of hematopoietic inductive BM
microenvironment is hampered by the lack of a
functional nonhematopoietic reconstitution system.
Here, we show that a deficiency of SH2-containing
inositol-50-phosphatase-1 (SHIP) in a nonhemato-
poietic host microenvironment enables its func-
tional reconstitution by wild-type donor cells. This
microenvironment reconstitution normalizes hema-
topoiesis in peripheral blood and BM and alleviates
pathology of spleen and lung in the SHIP-deficient
recipients. SHIP-deficient BMcontains a significantly
smaller population of multipotent stromal cells with
distinct properties, which may contribute to the
reconstitution by wild-type cells. We further demon-
strate that it is the nonhematopoietic donor cells that
are responsible for the reconstitution. Thus, we have
established a nonhematopoietic BM microenviron-
ment reconstitution system to functionally study
specific cell types in hematopoietic niches.
INTRODUCTION
The concept of hematopoietic stem cell (HSC) was first proven
by Till and McCulloch following their pioneer studies of blood
system regeneration in vivo (Till and McCulloch, 1961). A wealth
of experimentation since then formed a solid foundation for stem
cell research (Orkin and Zon, 2008). Nonhematopoietic cells
within the bone marrow (BM) are collectively referred to as the
BM microenvironment, which is essential for the maintenance
and function of the HSCs (Bianco, 2011; Morrison and Spradling,
2008; Purton and Scadden, 2008; Schofield, 1978; Taichman,
2005). Nonhematopoietic cell types including mesenchymal-Devederived osteoblasts, endothelial cells, and subendothelial retic-
ular cells (pericytes) have been detected in the BMmicroenviron-
ment and have demonstrated concerted roles in regulating
hematopoiesis (Calvi et al., 2003; Ding et al., 2012; Kiel et al.,
2005; Omatsu et al., 2010; Sacchetti et al., 2007; Sugiyama
et al., 2006; Zhang et al., 2003). Currently evolving concepts
hypothesize that quiescent, long-term repopulating cells are in
contact with the osteoblasts whereas more committed and
proliferating hematopoietic stem and progenitor cells are in con-
tact with the vasculature. However, in vivo imaging also sug-
gested that the dichotomy between the endosteal and vascular
niche is anatomically impossible (Lo Celso et al., 2009; Xie
et al., 2009). Thus, the nature of the BM microenvironment and
the relative contribution of each niche component to hematopoi-
esis remain elusive.
The study of HSCs has flourished after the establishment of a
functional reconstitution assay in which the donor HSCs home to
the marrow niches, engraft, proliferate, and eventually reconsti-
tute the whole hematologic and immunologic repertoire of the
lethally or sublethally irradiated recipient mice (Spangrude
et al., 1988). In comparison, the study of the BM microenviron-
ment is lagging far behind, partially due to the lack of a model
system to functionally study individual cell types involved in the
BMmicroenvironment through nonhematopoietic reconstitution.
A search for strategies to reconstitute the BMmicroenvironment
is warranted.
A dysfunctional BM microenvironment is now believed to
contribute to the development of hematologic diseases such
as myeloproliferative syndrome, myelodysplasia, leukemia, and
multiple myeloma (Lane et al., 2009). In hematologic malig-
nancies, there are dynamic interactions between leukemic cells
and cells of the BM microenvironment. Recent studies indicate
that leukemogenic events in the hematopoietic system may
create a tumormicroenvironment (Colmone et al., 2008) or trans-
form the niche into a milieu with dominant signals promoting and
sustaining abnormal cell growth (Jones and Wagers, 2008;
Li and Neaves, 2006). On the other hand, experiments in which
selective gene targeting within BM microenvironment leading to
deletion of the retinoic acid receptor g (Walkley et al., 2007a),
retinoblastoma (Walkley et al., 2007b), or Dicer1 specifically
in osteoprogenitors (Raaijmakers et al., 2010) have provided
critical evidence for genetic changes in the microenvironmentlopmental Cell 25, 333–349, May 28, 2013 ª2013 Elsevier Inc. 333
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SHIP KO Enables BM Microenvironment Reconstitutioncontributing to or required for leukemogenesis. Furthermore,
donor-cell-derived hematopoietic disease is a well-recognized
occurrence in allogeneic BM transplant recipients (Flynn and
Kaufman, 2007), which provides clinical evidence implicating
the BM microenvironment in leukemia development. In addi-
tion, multiple myeloma is an incurable blood disease character-
ized by clonal proliferation of malignant plasma cells, where
the BM microenvironment has a pivotal role in tumor patho-
genesis (Raab et al., 2009). A complex interplay is involved
in these hematologic diseases and provides a rationale for
targeting the BM microenvironment. However, functional recon-
stitution of a pathologic BM microenvironment through BM
transplantation has not been possible. In standard irradiation
and chemical ablation, the BM stroma remained functionally
intact, where damaged sinusoidal endothelial cells could be
replaced by host endothelial cells (Bierkens et al., 1991; Li
et al., 2008). Thus, novel strategies to replace a diseased BM
microenvironment are needed.
SH2-containing inositol-50-phosphatase-1 (SHIP) hydrolyzes
the phosphatidylinositol-3-kinase (PI3K) product phosphatidyli-
nositol-3,4,5-triphosphate [PI(3,4,5)P3] to PI(3,4)P2. SHIP
blunts PI3K-initiated signaling and prevents membrane recruit-
ment and activation of pleckstrin homology domain-containing
kinases (e.g., AKT and PDK) that serve as effectors of PI3K
signaling (Rohrschneider et al., 2000). Within the SHIP-deficient
mice a chronic progressive hyperplasia of myeloid cells
was observed, perhaps at the expense of B-cell production.
SHIP knockout (KO) myeloid progenitors had enhanced
responsiveness to cytokines and were less susceptible to
apoptotic stimuli in vitro. Increased proliferation and decreased
apoptosis may also contribute to the expanded HSC com-
partment in SHIP KO mice, though these HSCs have compro-
mised homing and repopulating ability (Desponts et al., 2006;
Helgason et al., 1998, 2003; Liu et al., 1999). SHIP was initially
thought to be restricted to hematopoietic cells, but it is now
apparent that most cells of the BM and blood express SHIP.
Hazen et al. demonstrated SHIP expression and participation
in the function of nonhematopoietic cells of the BM, and
SHIP KO mice had elevated levels of a number of hematopoi-
etic cytokines in the serum (Hazen et al., 2009). In current
study, we discovered that deficiency of SHIP in a nonhemato-
poietic host microenvironment could efficiently enable its
functional reconstitution by wild-type (WT) nonhematopoietic
donor cells. Thus, we have established a model reconstitution
system to functionally study specific cell types in the hemato-
poietic niches.Figure 1. SHIP Deficiency in the BM Microenvironment Determined De
(A) BM cells of CD45.1WTmice were transplanted into lethally irradiated CD45.2
mice were also transplanted into lethally irradiated CD45.2 SHIP KO mice.
(B) Examples of genotyping by FACS analysis of CD45.1+ SHIP KOmice (left, cells
(C) Representative FACS profiles of hematopoietic cell lineage analysis in PB of
(D and E) Absolute blood cell number (D) and donor-derived blood cell composi
(F and G) Transplanted WT BM cells acquired a SHIP KO hematopoietic phenoty
Shown are donor chimerism (similar for both WT-to-WT and WT-to-KO) and don
(H and I) Transplantation of WT BM cells to the SHIP KO mice could not rescue
transplantation. (H) The apparent difference of spleen and femur betweenWT and
KO mouse at comparable age are also shown. (I) Quantification of the spleen w
lymphocytes (3103); RBC, red blood cells (3106); PLT, platelets (3105).
Data in (D), (E), (G) and (I) are mean ± SEM.*p < 0.05; **p < 0.01 (two-tailed t tes
DeveRESULTS
A SHIP-Deficient Niche Leads to Impaired
Hematopoiesis
Consistent with the reported data, we observed that SHIP KO
mice had significantly higher myeloid population and lower
B-cell population in both peripheral blood (PB) and the BM
compared to WT mice (data not shown). To provide direct
evidence that SHIP disruption in the HSC niche is responsible
for the observed hematopoiesis defect, we performed reverse
transplantation experiments where whole BM cells from
CD45.1+ WT mice were intravenously transplanted into lethally
irradiated CD45.2+ WT or SHIP KO mice. As a control, whole
BM cells from CD45.1+ SHIP KO mice were transplanted into
lethally irradiated CD45.2+ SHIP KO mice (Figures 1A and 1B).
Four weeks after transplantation, all three experimental groups
(WT-to-WT, WT-to-KO, and KO-to-KO) achieved equally high
chimerism in PB (CD45.1-PE+ and CD45.2-APC populations;
Figure 1C). Both complete blood cell count and lineage analysis
indicated that WT-to-KO and KO-to-KO recipients exhibited a
SHIP KO hematopoietic phenotype, where CD45.1+ donor-
derived hematopoietic cells produced a significantly higher
myeloid population and a significantly lower B-cell population
in PB compared to WT-to-WT recipients (Figures 1D and 1E).
Similar to what was observed in PB, despite a comparable
donor-cell chimerism in the BM (CD45.1-PE+ and CD45.2-
APC populations), the donor-derived myeloid cell population
in WT-to-KO recipients was significantly higher than that of the
WT-to-WT recipients (Figures 1F and 1G). Earlier studies (Helga-
son et al., 1998; Liu et al., 1999) as well as our own observation
indicated that SHIP KOmice suffer from profound splenomegaly
and have fewer red blood cells in the BM than WT mice. Large
spleen and pale femurs were phenotypical characteristics of
SHIP KO mice. The spleen size and femoral appearance
between WT-to-WT and WT-to-KO recipients remained readily
distinguishable, with the latter nearly identical to those of the
SHIP KO mice (Figures 1H and 1I). In addition, we transplanted
whole BM cells from CD45.2+ SHIP KO mice into lethally
irradiated CD45.1+ WT recipients. The results at 4 weeks after
transplantation indicated that SHIP KO cells had a diminished
ability to form chimerism in WT recipients. However, the levels
of SHIP KO donor-derived myeloid cells and B cells were com-
parable to those of the WT-to-WT recipient mice (Figure 2).
Taken together, these results suggested that SHIP deficiency
in the BM microenvironment was responsible for the defective
hematopoietic phenotype observed in the SHIP KO mice.fective Hematopoiesis at 4 Weeks Posttransplantation
WTmice or littermate SHIP KOmice. As a control, BM cells of CD45.1 SHIP KO
from donor mice) and CD45.2+ SHIP KOmice (right, cells from recipient mice).
transplant recipients.
tion (E) in PB of transplant recipients.
pe in the BM of SHIP KO recipient mice 4 weeks after reverse transplantation.
or-derived myeloid cell populations (higher in WT-to-KO than in WT-to-WT).
the altered spleen size and the gross appearance of femur at 4 weeks post-
SHIP KO recipients and representative pictures of spleen and femur of a SHIP
eight difference. WBC, white blood cells (3103); NE, neutrophils (3103); LY,
t). See also Figure S1.
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Figure 2. SHIP Disruption in Hematopoietic Lineages Led to Impaired Homing and Engraftment of These Cells but Was Not Responsible for
the Hematopoiesis Defects Observed in the SHIP KO Mice
(A) Experimental design for transplant assays.
(B) Representative FACS lineage analysis.
(C) Absolute cell number in PB of WT transplant recipient mice. Total white blood cell count and lymphocyte count were lower in KO-to-WT transplant recipients.
(D) Donor-derived blood cell composition in PB ofWT transplant recipient mice. Total donor chimerism and donor-derived T-cell percentage were lower in KO-to-
WT transplant recipients. WBC, white blood cells (3103); NE, neutrophils (3103); LY, lymphocytes (3103); RBC, red blood cells (3106); PLT, platelets (3105).
Data in (C) and (D) are mean ± SEM. **p < 0.01; ***p < 0.001 (two-tailed t test).
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production in the KO-to-WT recipient, indicating that SHIP may
also play a role in T-cell recovery after irradiation.
SHIP Deficiency in the Niche Enables Its Reconstitution
Many genes, such as retinoic acid receptor g (Walkley et al.,
2007a), have been implicated in niche function. Disruption of
these genes also leads to hematopoiesis defects. These defects
remained even after the WT-to-KO reverse transplantation.
Intriguingly, in the WT-to-SHIP KO recipients, the levels of
both myeloid and B cell populations in PB shifted toward those
of the WT-to-WT recipient mice at 8 and 12 weeks (Figure S1
available online) and 16 weeks after reverse transplantation
(Figures 3A–3C; Figure S2G). The similar shift was also observed
in the BM (Figures 3D and 3E; Figures S2A and S2B), although
it was somewhat weaker compared to the shift in the PB
(Figure 3E). The spleen size of the WT-to-KO recipients at
16 weeks was still larger than that of the WT-to-WT recipients,
but it was significantly smaller compared to that of the KO-
to-KO recipients (Figure 3F). Another prominent characteristic
of the SHIP KO mouse is the elevated cellularity in the lung
due to myeloid cell infiltration (Helgason et al., 1998). This
phenotype was also significantly reversed to a much lesser
extent in the WT-to-KO recipients (Figure 3G; Figure S2C). All
of these results indicate that transplantation of WT whole BM
cells may gradually reconstitute the BM microenvironment in
SHIP-deficient mice.336 Developmental Cell 25, 333–349, May 28, 2013 ª2013 Elsevier InWe next directly investigated the structure of the BM. Hema-
toxylin and eosin (H&E) staining as well as immunohistochemical
staining (IHC) using an antibody against adipocyte-specific peril-
ipin of bone sections revealed that SHIP KO mice had no
discernible adipocytes in the trabecular region of the femur
and had significantly fewer adipocytes in the caudal vertebrae
compared toWTmice (Figure 3H; Figures S2D and S2E). Subse-
quent histological analysis showed that the trabecular region of
femurs of the WT-to-KO recipients contained numerous adipo-
cytes similar to the WT-to-WT control mice, but in stark contrast
to the KO-to-KO recipient mice (Figure 3I; Figure S2F). As illus-
trated in Figure 1H, pale femurs were phenotypical characteris-
tics of SHIP KO mice (Figure 3I).
To definitively prove that transplantation of WT whole BM cells
had reconstituted the BM microenvironment in the SHIP-defi-
cient mice, a second reverse transplantation was performed in
the CD45.1 chimera mice at 16 weeks after the first reverse
transplantation (Figure 4A). Four weeks after the second reverse
transplantation, similar to WT-to-WT recipients, WT-to-KO re-
cipients exhibited a WT hematopoietic phenotype, in contrast
to KO-to-KO recipients (Figures 4B–4D), confirming that SHIP
KO chimera mice already possessed a WT BM microenviron-
ment. To further demonstrate that a WT hematopoiesis had
been established in the SHIP KO chimera mice, lineage
(CD3e, CD4, CD8a, B220, CD19, Gr-1, and CD14),
Sca-1+, c-kit+ (LSK) hematopoietic stem and progenitor
cells (Morrison and Weissman, 1994) were isolated from thec.
(legend on next page)
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SHIP KO Enables BM Microenvironment ReconstitutionWT-to-KO recipients and transplanted into lethally irradiated WT
mice (Figure 4E). As expected, all recipient mice exhibited a WT
hematopoietic phenotype (Figures 4F–4H).
Nonhematopoietic Donor Cells Accomplish Niche
Reconstitution
Transplantation of WT whole BM cells to SHIP KO mice con-
verted the BM microenvironment from a SHIP KO phenotype
to a WT phenotype. To determine which population of the trans-
planted WT BM cells contributed to the nonhematopoietic
reconstitution in the SHIP KO recipient mice, we combined WT
hematopoietic cells (CD45+ and/or Ter119+) (WT-HEM) and
SHIP-deficient nonhematopoietic cells (CD45 and Ter119)
(KO-N-HEM) in a ratio of 100:1, which is comparable to the
composition found in normal BM (nonhematopoietic cells were
approximately 0.5%–1% of the BM cells) and then transplanted
them into lethally irradiated SHIP KOmice (Figure 5A). The result-
ing donor chimerism after transplantation was significantly lower
than that of the WT (whole BM)-to-KO transplantation. Although
the absolute numbers of donor-derived white blood cells were
low at 4 weeks posttransplantation, they consisted primarily of
myeloid cells with very few lymphocytes (Figures 5B–5D). This
SHIP KO hematopoietic phenotype persisted at both 4 weeks
and 16 weeks after transplantation (Figures 5E–5H), suggesting
that WT hematopoietic donor cells were not sufficient to recon-
stitute the SHIP-deficient microenvironment and WT nonhema-
topoietic cells were critical for successful niche reconstitution.
Consistently, the pathological phenotype associated with SHIP
deficiency also remained when SHIP KO nonhematopoietic cells
were used as donor cells (Figures 5I–5K). We also analyzed the
number of LSK cells in the BM of WT-HEM + KO-N-HEM recip-
ients, which appeared similar to that of SHIP KOmice (Figure 5L;
Figure S3A). In a similar experiment, we transplanted WT
hematopoietic cells alone (WT-HEM) into lethally irradiated
SHIP KO mice (Figure 6A). Without WT nonhematopoietic cells,
the resulting donor chimerism after transplantation was signifi-
cantly lower than that of the WT (whole BM)-to-KO transplanta-
tion. Similarly, despite minuscule amount of donor-derived white
blood cells, they consisted primarily of myeloid cells with very
few lymphocytes, a phenotype of the SHIP KO mice (Figures
6B–6D). The recipient mice eventually died between 4 and
7 weeks posttransplantation (Figure 6E). We then adopted a
technique reported by Morikawa et al. (2009) to isolate CD45,
Ter119, PDGFRa+, and Sca-1+ (PaS) multipotent stromal cells
from mouse BM (Figure 6F). We combined WT hematopoietic
cells and WT PaS cells to transplant into lethally irradiated WT
or SHIP KOmice (Figure 6G). After 16 weeks, SHIP KO recipients
had significantly lower chimerism than WT recipients. However,Figure 3. Transplantation ofWTWhole BMCells Reversed theHematop
(A–E) Transplantation of WT whole BM cells reversed the hematopoietic phenotyp
from transplant recipients at 16 weeks posttransplantation. (B and C) Absolute
transplant recipients at 16 weeks posttransplantation. (D and E) Analysis of BM h
cells (E). WBC, white blood cells (3103); NE, neutrophils (3103); LY, lymphocyte
(F–I) Transplantation of WT whole BM cells alleviated pathological phenotype and
of spleen and quantification of spleen weight of WT-to-WT, WT-to-KO, and KO-to
and quantification of lung cellularity of WT-to-WT, WT-to-KO, and KO-to-KO tran
H&E staining and quantification of femoral adipocytes inWT and SHIP KOmice. (I)
of femoral adipocytes of WT-to-WT, WT-to-KO, and KO-to-KO transplant recipie
Data in (B), (C), (D), (E), (F), (G), (H), and (I) are mean ± SEM.*p < 0.05; **p < 0.01
338 Developmental Cell 25, 333–349, May 28, 2013 ª2013 Elsevier Inthe SHIP KO recipients exhibited hematopoietic lineage compo-
sition in PB and BM comparable to that of the WT recipients
(Figures 6H–6L). Collectively, these results demonstrate that
WT hematopoietic cells alone were not sufficient to sustain
hematopoiesis in lethally irradiated SHIP KO mice and WT non-
hematopoietic cells, including the PaS cells, are required for the
BM reconstitution in SHIP KO recipients.
We applied several different approaches to quantify nonhema-
topoietic chimerism in the BM of SHIP KO recipients. First, under
rigorous gating conditions, we isolated CD45 and Ter119 non-
hematopoietic cells from the BM (Figures 7A and 7B). We then
used conventional PCR (Figure 7C) to detect and quantitative
real-time PCR (Figure 7D) to measure WT SHIP DNA in SHIP
KO recipients. Next, we quantified Y-chromosome-specific
DNA in sex-mismatched recipients to demonstrate that while
WT-to-KO transplantation resulted in chimerism, WT-to-WT
transplantation did not (Figures 7E and 7F). Finally, wemeasured
red fluorescent protein (RFP) DNA in donor-derived RFP-gene-
positive cells in non-RFP recipients (Figures 7G and 7H). While
there was no significant chimerism in WT-to-WT recipients, the
nonhematopoietic chimerism estimated by all three quantitative
PCR methods was about 30%–40% in the WT-to-KO recipients
at 16weeks after the reverse transplantation (Figures 7D, 7F, and
7H). In the above experiments, the targeted nonhematopoietic
cell population is a mixture of multiple cell types, including multi-
potent BM stromal cells, fibroblasts (reticular connective tissue),
and endothelial cells. In order to examine the reconstitution of
multipotent stromal cells in the WT-to-KO recipients, we per-
formed a colony-forming assay (CFU-Fs) (Friedenstein et al.,
1974; Kuznetsov et al., 2009) with the CD45Ter119 BM cells
from WT-to-KO recipients (Figure 7I). Total genomic DNA was
isolated from individual colonies, and genotyping was performed
to determine whether the cells were of WT donor or of SHIP KO
recipient origin. The results indicated that up to 70%of the multi-
potent BM stromal cells of the KO recipients came from a WT
donor (Figure 7J). Taken together, these results directly show
that cells that originated from transplanted nonhematopoietic
cells were indeed incorporated into the BM microenvironment
in the SHIP KO recipient mice and suggest that there is a selec-
tive advantage to allow engraftment of WT nonhematopoietic
cells in the SHIP KO BM microenvironment. It is noteworthy
that in the third approach we used whole BM cells from RFP
(or GFP) transgenicmice for transplantation.We initially intended
to use fluorescence-activated cell sorting (FACS) to quantify
nonhematopoietic chimerism in SHIP KO recipient mice. Inter-
estingly, we discovered that BM cells in the nonhematopoietic
compartment of the RFP or GFP mice were not fluorescent (Fig-
ure S4). It has been a problem in the BM stromal field thatoietic Phenotype andAlleviatedPathology in the SHIP-DeficientMice
e. (A) Representative FACS profiles of hematopoietic cell lineage analysis of PB
blood cell number (B) and donor-derived blood cell composition (C) in PB of
ematopoietic cell composition both in total BM cells (D) and in donor-derived
s (3103); RBC, red blood cells (3106); PLT, platelets (3105).
restored adipogenesis in the BM of SHIP-deficient mice. (F) Gross appearance
-KO transplant recipients. (G) H&E staining of lung histological sections (2003)
splant recipients. (H) Representative femur and caudal vertebrae sections after
Gross appearance of femur, H&E staining of femur sections, and quantification
nts.
; ***p < 0.001 (two-tailed t test). See also Figure S2.
c.
(legend on next page)
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SHIP KO Enables BM Microenvironment Reconstitutionoftentimes a reporter gene is silenced in these cells for reasons
that are not clear. In both mice, the expression of RFP or GFP
is under the control of cytomegalovirus early enhancer/chicken
b-actin (CAG) promoter. Despite the ability of the CAG promoter
to drive gene expression in almost all tissues, its activity appears
to be developmentally regulated in specific cell lineages (Baup
et al., 2009). Accordingly, we decided to quantify the RFP DNA
in the SHIP KO recipients using PCR instead (Figure 7H).
SHIP-Deficient BM Microenvironment
We next explored the mechanism by which the SHIP KO BM
microenvironment affects normal hematopoiesis. Using a laser
scanning cytometry imaging technique, we found that the SHIP
KO mouse BM had a similar number and distribution of c-kit+
progenitor cells in the femur as WT mice despite the absence
of adipocytes (Figures 8A–8C). Both WT and SHIP KO mouse
BM contained comparable total number of cells. As previously
reported, SHIP KO mouse BM contained 5-fold more LSK
hematopoietic stem and progenitor cells (Figure 8D; Figure S3A).
We also measured the amount of BM multipotent stromal cells,
which can give rise to multiple mesenchymal cell lineages,
including chondrocytes, osteocytes, and adipocytes. Intrigu-
ingly, SHIP KO mouse BM contained about 10-fold less
CD45, CD11b, CD29+, CD44+, CD105+, CD106+, and
Sca-1+multipotent stromal cells (Zhu et al., 2010) (Figure 8E; Fig-
ure S3B) and about 1-fold less CD45, Ter119, PDGFRa+, and
Sca-1+ (PaS) multipotent stromal cells (Morikawa et al., 2009)
(Figure 8F). Initial isolation of BM stromal cells based on their
plastic-adherence properties (Peister et al., 2004) indicated
that significantly more cells, presumably macrophages and
monocytes, from the SHIP KO mouse BM adhered to the plastic
tissue culture dish (Figure S5A). In a separate cell-adhesion
assay under controlled shear flow,we could confirm thatmyeloid
cells from SHIP KO mouse BM exhibited a higher degree of
adhesion to a plastic surface than those from WT mouse BM
(data not shown). We then performed a CFU-Fs (Friedenstein
et al., 1974; Kuznetsov et al., 2009) using CD45Ter119 BM
stromal cells to exclude possible contamination fromBMmacro-
phages. The results indicated that both WT and SHIP KO BM
stromal cells had similar abilities to form fibroblast-like colonies
(Figure S5B).
In order to further study BM multipotent stromal cells, we iso-
lated PaS multipotent stromal cells from WT and SHIP KO
mouse BM (Figure 6F). SHIP KO PaS cells formed fewer adipo-
cytes compared to WT PaS cells (Figure 8G). Interestingly,
although SHIP KO PaS cells formed fewer adipocytes, these
cells appeared to have produced more lipid droplets than WTFigure 4. Conversion to a Normal Hematopoietic Niche and Establishm
(A–D) Conversion to a normal hematopoietic niche in the SHIP KO chimera was c
were transplanted into lethally irradiated WT CD45.1 chimeric mice or littermate S
were transplanted into lethally irradiated SHIP KO CD45.1 chimeric mice. (B) Repr
reverse transplant recipients at 4 weeks posttransplantation. (C and D) The absolu
second reverse transplant recipients at 4 weeks posttransplantation.
(E–H) Normal hematopoiesis established in the SHIP KO chimera was confirmed b
mice were transplanted into lethally irradiated SHIP KO mice. After 16 weeks, LS
lethally irradiated WT mice. (F) Representative FACS profiles of hematopoietic ce
blood cell number (G) and donor-derived blood cell composition (H) in PB of sec
WBC, white blood cells (3103); NE, neutrophils (3103); LY, lymphocytes (3103); R
mean ± SEM. *p < 0.05; **p < 0.01 (two-tailed t test).
340 Developmental Cell 25, 333–349, May 28, 2013 ª2013 Elsevier Inadipocytes as judged by oil red O staining (Figure 8G). Western
blots of whole BM cells and IHC showed that SHIP KO BM
adipocytes expressed a much higher level of adiponectin in
both femur and caudal vertebrae compared to WT mice (Fig-
ure 8H; Figure S5C). Thus, the capability of fat-cell formation
in vitro closely reflected the aforementioned in vivo observations
of SHIP KO mouse BM. SHIP KO PaS cells also appeared to
have an impaired ability to form an osteoblastic nodule upon
osteogenic induction (Figures S5D and S5E). It is noteworthy
that a previous study by Takeshita et al. showed that SHIP
does not modulate bone formation in vivo (Takeshita et al.,
2002; please also see Discussion).
It was recently reported that tumor suppressor retinoblastoma
protein (RB) can regulate interactions between HSCs and BM
microenvironment (Walkley et al., 2007b) as well as cell-fate
choice and lineage commitment in vivo (Calo et al., 2010). How-
ever, the level of phospho-RB was similar between the WT and
SHIP KOPaS cells (Figure 8I). Since progression of a cell through
G1 and S phase requires inactivation of RB by phosphorylation
(Harbour and Dean, 2000), similar level of phospho-RB indicates
normal cell-cycle progression of SHIP KO PaS cells. Further
investigation revealed that SHIP KO PaS cells expressed less
FOXO1 and diminished levels of phospho-PPARg but an equiv-
alent level of total PPARg comparedwithWTPaScells (Figure 8I).
Both FOXO1 and phosphorylation of PPARg are known to inhibit
PPARg activities in adipogenesis (Hu et al., 1996; Nakae et al.,
2003), and depletion of FOXO1 prevents osteoblast differentia-
tion (Siqueira et al., 2011). SHIP KO PaS cells also expressed
less AKT and phospho-AKT and produced a larger amount of
the 12 kDa cleaved caspase-3 fragment (Figure 8I). Consistently,
SHIP KO PaS cells were more prone to apoptosis in vitro under
normal culture conditions when compared with WT PaS cells
(Figure 8J). A recent study also showed that SHIP inhibition
can cause apoptosis of hematopoietic cancer cells (Brooks
et al., 2010). Starting with the same number of BM PaS cells,
the total number of cells derived from SHIP KO PaS cells was
about 40% less than that from theWT PaS cells in normal culture
over 7 days (Figure 8K). We also observed that SHIP-deficient
CD45Ter119 BM stromal cells lost viability in long-term cul-
ture (Figures S5F and S5G). These results are consistent with
earlier PaS cell isolation (Figure 8F) and apoptosis results (Fig-
ure 8J). While irradiated WT BM PaS cells recovered rapidly,
the number of irradiated SHIP KO BM PaS cells did not increase
over time (Figure 8L). Thus, the propensity of apoptosis and
impaired growth after irradiationmay contribute to the nonhema-
topoietic reconstitution by WT donor cells in the SHIP-deficient
recipient mice.ent of Normal Hematopoiesis in the SHIP KO Chimera
onfirmed by a second reverse transplantation. (A) BM cells of CD45.2 WT mice
HIP KO CD45.1 chimeric mice. As a control, BM cells of CD45.2 SHIP KOmice
esentative FACS profiles of hematopoietic cell lineage analysis in PB of second
te blood cell number (C) and donor-derived blood cell composition (D) in PB of
y a secondary transplantation. (E) BM cells of red fluorescent protein (RFP) WT
K hematopoietic stem and progenitor cells were isolated and transplanted into
ll lineage analysis in PB of secondary transplant recipients. (G and H) Absolute
ondary transplant recipients (red bars) compared with WT mice (blue bars).
BC, red blood cells (3106); PLT, platelets (3105). Data in (C), (D), (G), and (H) are
c.
(legend on next page)
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Hematopoiesis is the process by which all lineages of blood cells
are produced in a hierarchical and stepwise manner in the BM,
and at the apex of this hierarchy are the HSCs (Orkin and Zon,
2008). Previous studies suggested that SHIP might play a role
in HSC signaling and thus HSC homeostasis, homing, and re-
constituting potential (Desponts et al., 2006; Helgason et al.,
2003). On further investigation, our data support the notion that
SHIP KO mice have a distinct state of hematopoiesis that in-
cludes a defective hematopoietic cellular composition skewing
toward myeloid cells at the cost of lymphopoiesis both in the
PB and BM and have significantly more HSCs despite compara-
ble total BM cellularity. A recent study by Hazen et al. suggested
that the defective hematopoiesis in SHIP KO mice was not HSC
cell autonomous (Hazen et al., 2009). In the present study, we
provided direct evidence by using reverse transplantation to
demonstrate that a SHIP-deficient BMmicroenvironment indeed
can determine defective hematopoiesis at 4 weeks posttrans-
plantation. However, this is the prelude of what we observed at
later time points, when hematopoiesis in SHIP KO recipients
was surprisingly normalized. We then investigated what might
have caused such normalization, which revealed that a signifi-
cant nonhematopoietic chimerism took place in the BM of
SHIP KO mice. Thus, a significant nonhematopoietic chimerism
resulting in a normal hematopoiesis has been demonstrated.
Mechanistically, we studied PaS cells from the BM of SHIP KO
mice and discovered that their distinct properties, including pro-
pensity of apoptosis and impaired growth after irradiation, may
contribute to the nonhematopoietic chimerism. Furthermore,
our results indicate that WT nonhematopoietic cells are required
for the BM reconstitution in SHIP KO recipients.
Earlier studies by Hazen et al. also demonstrated that circu-
lating levels of multiple cytokines were elevated in SHIP KO
mice (Hazen et al., 2009). During the initial period following
reverse transplantation of WT BM cells, aberrant cytokine levels
were likely to persist in the BM microenvironment of SHIP KO
recipients, which may have contributed to the SHIP KO hemato-
poietic phenotype observed at 4 weeks after transplantation. It is
conceivable that once the WT nonhematopoietic cells have suc-
cessfully engrafted and started to proliferate and differentiate,
the reconstitution of the BM microenvironment in SHIP KOFigure 5. Transplanted WT Nonhematopoietic Cells Were Responsib
Recipients
(A) Strategy to combine WT hematopoietic cells (WT-HEM) and SHIP KO nonhem
(B) Representative FACS profiles of donor-cell chimerism and hematopoietic cell
4 weeks posttransplantation.
(C and D) Absolute blood cell number (C) and donor-derived blood cell composit
posttransplantation.
(E–L) At 16 weeks posttransplantation, a SHIP KO hematopoietic phenotype and
nonhematopoietic donor cells were replaced with SHIP-deficient nonhematopoie
hematopoietic cell lineage analysis of PB of WT-HEM + KO-N-HEM to KO transp
number (F) and the percentage among donor-derived cell population (G) in the P
poietic cell composition (percentage) in the BM of transplant recipients at 16 w
betweenWT whole BM recipients and WT-HEM + KO-N-HEM recipients at 16 we
(black arrows) remained visible in the lungs of WT-HEM + KO-N-HEM transplant r
N-HEM transplant recipients (n = 4). (L) Representative FACS analysis (left) and q
HEM + KO-N-HEM recipients at 16 weeks after reverse transplantation.
WBC, white blood cells (3103); NE, neutrophils (3103); LY, lymphocytes (3103); R
and (L) are mean ± SEM.*p < 0.05; **p < 0.01; ***p < 0.001 (two-tailed t test). See
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esis. On the other hand, it is also possible that the normal cyto-
kine responsiveness of the WT hematopoietic progenitors
contributed to the observed normalization of the hematopoiesis.
To further dissect the potential mechanisms involved, we per-
formed a series of experiments to validate our findings. First,
whole BM cells from SHIP KO mice were transplanted into WT
mice, and we found that overall levels of donor-derived myeloid
cells and B cells were comparable betweenWT and SHIP KO cell
recipients at 4 weeks after transplantation. At 16 weeks after the
transplantation, the SHIP KO cell recipients exhibited elevated
myelopoiesis and reduced lymphopoiesis as reported previously
(Helgason et al., 2003). In the second set of experiments,
hematopoietic cells from WT mice combined with nonhemato-
poietic cells from SHIP KO mice were transplanted into lethally
irradiated SHIP KO mice. In this setting, however, the donor
chimerism was so poor that total white blood cell levels in the
SHIP KO recipients were extremely low. Interestingly, those
successfully engrafted donor cells differentiated primarily into
myeloid cells. In the third set of experiments, WT hematopoietic
cells alone were transplanted into SHIP KOmice. They exhibited
similar hematopoietic phenotype as WT-HEM + KO-N-HEM
recipients. All the SHIP KO recipients in the latter experiment
eventually died 4–6 weeks posttransplantation. In the next set
of experiments, we combined WT hematopoietic cells and WT
PaS cells to transplant into lethally irradiated SHIP KO mice,
and these SHIP KO recipients exhibited a WT hematopoietic
lineage composition in PB and BM after transplantation. Collec-
tively, these experiments indicated that the nonhematopoietic
reconstitution observed in the BM of SHIP KO mice was not
caused by the transplanted WT hematopoietic cells and the
WT nonhematopoietic cells, including the PaS cells, were
required to establish normal hematopoiesis in the recipients.
Although there was no comprehensive study on hematopoie-
sis after a double irradiation and transplantation, tandem
hematopoietic stem cell transplantation has been a feasible
clinical option in treating patients with severe blood malig-
nancies, where total body irradiation was only given in one
transplant procedure (Monjanel et al., 2011; Somlo et al.,
2011). Nevertheless, such tandem transplantation inspired us
to perform a second reverse transplantation to demonstrate
that SHIP KO chimeras, due to nonhematopoietic chimerism,le for the Reconstitution of BM Microenvironment in the SHIP KO
atopoietic cells (KO-N-HEM) in the transplantation.
lineage analysis of PB of WT-HEM + KO-N-HEM to KO transplant recipients at
ion (D) in PB of WT-HEM + KO-N-HEM to KO transplant recipients at 4 weeks
a pathological phenotype associated with SHIP deficiency persisted when WT
tic donor cells. (E) Representative FACS profiles of donor-cell chimerism and
lant recipients at 16 weeks posttransplantation. (F and G) Absolute blood cell
B of transplant recipients at 16 weeks posttransplantation. (H) Total hemato-
eeks posttransplantation. (I) Apparent and quantitative difference of spleen
eks after reverse transplantation. (J) Elevated cellularity and myeloid infiltration
ecipients (n = 4). (K) No discernible adipocytes in the femurs of WT-HEM + KO-
uantification (right) of total BM LSK cells of WT whole BM recipients and WT-
BC, red blood cells (3106); PLT, platelets (3105). Data in (C), (D), (F), (G), (H), (I)
also Figure S3.
c.
(legend on next page)
Developmental Cell
SHIP KO Enables BM Microenvironment Reconstitution
Developmental Cell 25, 333–349, May 28, 2013 ª2013 Elsevier Inc. 343
Developmental Cell
SHIP KO Enables BM Microenvironment Reconstitutionhad a functional BM microenvironment capable of normal
hematopoiesis. WT hematopoiesis established in the WT-to-
KO transplant recipients was further confirmed by a secondary
transplantation of the LSK hematopoietic stem and progenitor
cells.
Despite the advance in understanding genetic events leading
to pathogenesis of hematologic malignancies, significant im-
provements in therapeutic outcome based on these insights
have not been forthcoming in many cases. A dysfunctional BM
microenvironment is now also believed to contribute to disease
development. Thus, one potential therapeutic strategy is to
replace the defective microenvironment. So far, functional
replacement of a diseased BM microenvironment through BM
transplantation has not been possible. Despite the report by
Rombouts and Ploemacher (2003), in most studies of murine ex-
periments or in clinical transplantations where primary BM cells
were infused, donor nonhematopoietic stromal cells could rarely
be detected in the recipient BM (Laver et al., 1987; Morikawa
et al., 2009; Simmons et al., 1987). Our results withWT recipients
that had negligible nonhematopoietic chimerism in BM are
consistent with these reports. Here, we show that lipid phospha-
tase SHIP deficiency may enable a functional reconstitution of
BMmicroenvironment byWT cells. In this study, the total nonhe-
matopoietic chimerism in SHIP KO BM at 16 weeks after trans-
plantation was estimated to be about 30%–40%, which was
capable of producing a WT hematopoietic phenotype both in
PB andBM. To examine the reconstitution ofmultipotent stromal
cells in the WT-to-KO recipients, we performed CFU-Fs with the
CD45Ter119 BM cells from WT-to-KO recipients and found
that up to 70% of the BM multipotent stromal cells of the KO re-
cipients came from a WT donor. The numerous adipocytes seen
in the WT-to-KO recipients strongly indicate that donor multipo-
tent stromal cells were a major contributor in this reconstitution.
The study by Morikawa et al. (2009) showed that primary PaS
cells can home to appropriate sites and differentiate in response
to cues from the niche environment. However, significant
engraftment is only possible when the recipient’s BMmultipotent
stromal cells were debilitated by standard conditioning in suffi-
cient numbers to leave their niche available to the donor multipo-
tent stromal cells. Indeed, the propensity of apoptosis of SHIP
KO PaS cells and the lack of growth after irradiation could poten-
tially facilitate their replacement by WT PaS cells. Although we
showed that PaS cells were defective in the SHIP-deficient
mice, this cell type is not exclusively functioning as a HSC niche.
Normal hematopoiesis was restored only after the transplanta-
tion of WT PaS cells into the SHIP-deficient recipients. However,
this finding cannot completely rule out the possibility that theFigure 6. WT Nonhematopoietic BM Cells Were Required for the Reco
(A–E) WT hematopoietic cells alone were not sufficient to sustain hematopoiesis
hematopoietic cells (CD45+ and/or Ter119+,WT-HEM) alonewere transplanted int
absolute blood cell number, and (D) donor-derived cell population in the PB ofWT-
analysis of the recipients.
(F–L) WT PaS cells contribute to the formation of a hematopoietic microenvironme
are representative FACS profiles of WT and SHIP KO PaS cells. (G) Strategy of ex
were combined with isolated WT-PaS cells to transplant into either WT or SHIP K
number (I) and donor-derived cell population (J) in the PB at 16 weeks posttransp
BM cells (K) and in donor-derived cells (L).
WBC, white blood cells (3103); NE, neutrophils (3103); LY, lymphocytes (3103); R
(L) are mean ± SEM.*p < 0.05; **p < 0.01; ***p < 0.001 (two-tailed t test).
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critical for hematopoiesis. The SHIP-deficient BM may still
sustain different niche components such as osteoblastic cells
and vascular cells. Additionally, considering the splenomegaly
phenotype, it is possible that spleen may function as an alterna-
tive niche to rescue the defect in BM niche. Consistently, signif-
icant hematopoietic reconstitution was also observed in the
niche-defective SHIP KO mice at 16 weeks posttransplantation
(WT-HEM + KO-N-HEM to KO, Figures 5F–5H). Sacchetti et al.
have identified perivascular cells as multipotent stem cells within
the BM stroma (Sacchetti et al., 2007). Later, Mendez-Ferrer
et al. reported a subset of perivascular multipotent stromal cells
expressing nestin (Me´ndez-Ferrer et al., 2010), and Omatsu et al.
provided new insight on the CXCL12-abundant reticular cells
that support HSCs in BM (Omatsu et al., 2010). Besides osteo-
genic differentiation, these cells are also capable of differenti-
ating into adipocytes, which are thought to exert an inhibitory
role in hematopoiesis (Naveiras et al., 2009). Recently, Park
et al. reported that BM-derived multipotent stromal cells may
be a heterogeneous population with the newly identified Mx1+
population (Park et al., 2012). In addition, vascular cell adhesion
molecule-1 was also reported to be a relevant marker for BM
stromal cells (Chou et al., 2012). It is currently unclear whether
or how much these cell populations overlap (Nombela-Arrieta
et al., 2011).
The mechanisms triggering the reconstitution of hemato-
poietic inductive BMmicroenvironment in SHIP KOmice warrant
future investigation. We speculate that the significantly lower
multipotent stromal cell counts and their impaired function
(e.g., defective adipogenesis and elevated apoptosis) in SHIP
KOmicemay contribute to the reconstitution. SHIP KOPaS cells
are more prone to apoptosis and form fewer adipocytes in an
in vitro adipogenesis assay compared to WT PaS cells. Consis-
tently, our in vivo transplantation data also suggest defective adi-
pogenesis of SHIP-deficient BM multipotent stromal cells. A
small percentage of SHIP KO stromal cells can incorporate
into the SHIP KO recipient mice (Figure 7F). However, these cells
could never differentiate into mature adipocytes (Figure S2F).
Hematopoiesis could also be regulated by osteoblastic niches.
SHIP KO PaS cells appeared to have an impaired ability to
form an osteoblastic nodule upon osteogenic induction in an
in vitro assay (Figures S5D and S5E). However, a previous study
by Takeshita et al. showed that SHIP does not modulate bone
formation (osteogenesis) in vivo (Takeshita et al., 2002). Instead,
due to an increased number of hyperresorptive osteoclasts, the
three-dimensional trabecular volume fraction, trabecular thick-
ness, number, and connectivity density of long bones are allnstitution of BM Microenvironment in the SHIP KO Recipients
in lethally irradiated SHIP KO mice. (A) Strategy of experiments in which WT
o lethally irradiated SHIP KOmice. (B) Representative FACS analysis profile, (C)
HEM toKO recipients at 4weeks posttransplantation. (E) Kaplan-Meier survival
nt in the SHIP KO recipients. (F) Isolation of PaS cells by FACS sorting. Shown
periments in which WT hematopoietic cells (CD45+ and/or Ter119+, WT-HEM)
O mice. (H) Representative FACS analysis profile. (I and J) Absolute blood cell
lantation. (K and L) Analysis of BM hematopoietic cell composition both in total
BC, red blood cells (3106); PLT, platelets (3105). Data in (C), (D), (I), (J), (K) and
c.
Figure 7. Quantification of Nonhematopoietic Chimerism in the SHIP KO Mouse BM Microenvironment
(A) Strategy to detect WT SHIP DNA in SHIP KO recipients.
(B) Representative FACS profile of isolation of hematopoietic cells (CD45+ and/or Ter119+) and nonhematopoietic cells (CD45 and Ter119) fromWT and SHIP
KO mouse recipient BM is shown.
(C) Conventional PCR genotyping of hematopoietic and nonhematopoietic cells from the BM of transplant recipients. The SHIP WT band (72 bp) and SHIP KO
band (172 bp) are indicated.
(D) Quantitative real-time PCR determination of WT SHIP DNA in SHIP KO transplant recipients.
(E) Strategy to detect male DNA in female recipients.
(F) Quantitative real-time PCR determination of male DNA in female transplant recipients.
(G) Strategy to detect red fluorescent protein (RFP) reporter gene in non-RFP SHIP KO recipients.
(H) Quantitative real-time PCR determination of RFP reporter gene in non-RFP SHIP KO recipients. Nonhematopoietic cells from RFP BMwere isolated by using
APC-labeled anti-mouse CD45 and Ter119 antibodies.
(I) Strategy of colony-forming assay (CFU-Fs) with the CD45Ter119 BM stromal cells from WT-to-KO recipients. Four SHIP KO recipients were used in this
experiment; approximately 20 colonies from each mouse were selected for genomic DNA isolation.
(J) Conventional PCR was performed to determine the origin of individual colonies. Data are mean ± SEM.
*p < 0.05 (two-tailed t test). See also Figure S4.
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current study, we carefully examined the bone structure. The
thickness of the cortical bone was significantly reduced in the
SHIP KO mice as previously reported (Takeshita et al., 2002).
However, we could not detect significant increase or decrease
in trabecular bone in the femur and caudal vertebra in the SHIP
KO mice.DeveBy using a specific nonhematopoietic cell type that is geneti-
cally labeled in the BM transplantation, the nonhematopoietic
reconstitution in SHIP KOmice described here can be employed
to visualize the donor cells’ anatomic location after engraftment
and to functionally assess hematopoietic outcome in the recipi-
ents when this specific cell type is excluded from the BM trans-
plantation. Based on this model, the identity of the cells involvedlopmental Cell 25, 333–349, May 28, 2013 ª2013 Elsevier Inc. 345
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future. In a therapeutic setting, SHIP inhibition in patient’s BM
may be induced shortly before radiation therapy and transplan-
tation of healthy donor BM cells. Hematopoiesis in the recipient
patient may normalize once donor-derived nonhematopoietic
cells have successfully engrafted and thrived. Taken together,
our investigation suggests that nonhematopoietic reconstitution
in SHIP KOmouse BMmay provide amodel to functionally study
cell types involved in hematopoietic niches. More importantly,
selective inhibition of SHIP in patients may improve treatment
outcome by targeting both malignant hematopoietic cells and
the aberrant BM microenvironment.
EXPERIMENTAL PROCEDURES
Mouse Maintenance and Genotyping
Animal procedures followed protocols approved by the Institutional Animal
Care and Use Committee at Children’s Hospital Boston. The SHIP KO mice
were purchased from the Jackson Laboratory and maintained on a mixed
genetic background (129/C57BL/6). SHIP heterozygous mice were back-
crossed with either CD45.2+ C57BL/6 mice or CD45.1+ C57BL/6 mice (both
from Jackson). Over a period of 2 years of backcrossing, we generated both
CD45.2+ SHIP KO mice in C57BL/6 background and CD45.1+ SHIP KO mice
in C57BL/6 background. Every donor and recipient mouse used in the
transplantation experiments was carefully genotyped for its CD45.1 and/or
CD45.2 expression before the actual experiment. For further details, see the
Supplemental Experimental Procedures.
BM Cell Transplantation
Age-matched CD45.2+ C57BL/6 and CD45.1 (B6.SJL-Ptprca/BoyAiTac) mice
were purchased from Taconic (Hudson, NY). Donor whole BM cells were
collected and transplantations were carried out following two rounds of
5.2Gy lethal g-irradiation of recipient mice performed 3 hours apart. For further
details, see the Supplemental Experimental Procedures.
PaS Cell Isolation and Characterization
PaS cells were isolated and cultivated using reagents and methods as
described by Morikawa et al. (2009). For further details, see Supplemental
Experimental Procedures.
Determination of Nonhematopoietic Chimerism in the BM of SHIP
KO Recipients
Conventional PCR genotyping was performed to detect the presence of WT
and SHIP KO bands in hematopoietic and nonhematopoietic cells from the
BM of SHIP KO recipients. Quantitative real-time PCR was performed using
a CFX96 Thermal Cycler and iQ SYBR Green Supermix or iQ Multiplex Power-
mix from Bio-Rad. All primers were synthesized by Integrated DNA Technolo-
gies. For further details, see the Supplemental Experimental Procedures.Figure 8. Characterization of SHIP-Deficient BM Microenvironment
(A–C) SHIP KO mouse BM had a similar number and distribution of c-kit+ progen
trabecular region of femur fromWT andSHIP KOmice. Blood vessels (red) and c-k
respectively. Slides were counterstained with DAPI (blue). Images in the upper pa
each group. (B and C) Analysis of c-kit+ cell population showing similar numbers
(D–L) Disruption of SHIP led to reduced BMmultipotent stromal cell (BMMSC) po
cells. Comparison of LSK (D) andBMMSC (CD45, CD11b, CD29+, CD44+, CD10
(F) Comparison of PaS cell (CD45, Ter119, PDGFRa+, and Sca-1+) populations
obtained from two pairs of femur and tibia. (G) SHIP KOPaS cells formed fewer ad
oil red O staining (1003) at 14 days after adipogenic induction of WT and SHIP KO
in both femur and caudal vertebrae compared toWTmice.Western blots of whole
against adiponectin. Red arrows in IHC indicate adipocytes in SHIP KO mouse
gression, andmarkers of apoptotic process. (J) SHIP KO PaS cells were more pro
Representative growth curves of WT and SHIP KO PaS cells in regular culture. (L)
Data in (C), (D), (E), (F), (G), (H), (J), (K), and (L) are mean ± SEM. *p < 0.05; **p <
DeveStatistics
Analysis of statistical significance for indicated data sets was performed using
the Student’s t test capability on Microsoft Excel and GraphPad Prism.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and five figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2013.04.016.
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